drugset / Trial / NCT03624543
CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
Phase 2
Active not recruiting
51 enrolled
Canadian Cancer Trials Group
Stand Up To Cancer Canada-Canadian Cancer Society Breast Cancer Dream Team · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The standard or usual treatment for this disease is to undergo chemotherapy to slow the spread of the disease and relieve some symptoms of cancer. Patients will have already had at least one chemotherapy treatment for their disease at this stage.
Timeline
- Start
- 2019-02-14
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OCIFISERTIB | Small molecule | 32 mg | — |